Back
Barry Callebaut AG Vs. ResMed Industry Stock Comparison
Sell
43
BRRLY
Barry Callebaut AG
Last Price:
17.96
Seasonality Move:
-2.82%
Sell
37
RMD
ResMed
Last Price:
238.89
Seasonality Move:
9.63%
Sell
43
Barry Callebaut AG (BRRLY)
is a Sell
Is Barry Callebaut AG a Buy, Sell or Hold?
- The current Barry Callebaut AG [BRRLY] share price is $17.96. The Score for BRRLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- BRRLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $239.00. The Score for RMD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BRRLY Stock Price Chart
What is Barry Callebaut AG's stock price today?
-
The Barry Callebaut AG share price today is $17.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BRRLY is experiencing selling pressure, which indicates risk of future bearish movement.
RMD Stock Price Chart
BRRLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 58.41 | Buy |
| Chaikin Money Flow: | -4593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.28 - 17.86) | Buy |
| Bollinger Bands (100): | (16.11 - 17.67) | Buy |
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.17 | Buy |
| Relative Strength Index (14 RSI): | 48.53 | Sell |
| Chaikin Money Flow: | -1050033 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (237.55 - 250.79) | Sell |
| Bollinger Bands (100): | (200 - 236.14) | Buy |
BRRLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.87 | Buy |
| 20-day SMA: | 17.36 | Buy |
| 50-day SMA: | 16.63 | Buy |
| 200-day SMA: | 15.97 | Buy |
| 8-day EMA: | 17.74 | Buy |
| 20-day EMA: | 17.38 | Buy |
| 50-day EMA: | 16.94 | Buy |
| 200-day EMA: | 16.6 | Buy |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 242.7 | Sell |
| 20-day SMA: | 246.18 | Sell |
| 50-day SMA: | 229.88 | Buy |
| 200-day SMA: | 201.27 | Buy |
| 8-day EMA: | 243.22 | Sell |
| 20-day EMA: | 242.45 | Sell |
| 50-day EMA: | 232.43 | Buy |
| 200-day EMA: | 208.09 | Buy |
Barry Callebaut AG Earnings Growth & BRRLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.19 per share, and an increase next year of $1.40 per share.
Barry Callebaut AG Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ResMed Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||